Company to host public (L)earnings call on February 25 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Salt Lake City, UT, Feb. 18, 2026 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, before the open of the financial markets. Recursion will host a (L)earnings Call on February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT. The company will broadcast the live stream from Recursion’s X, LinkedIn, and YouTube accounts. Investors, analysts, and the public will be able to ask questions of the company by submitting questions here: https://forms.gle/TQ4vgUTLKsFmikcu6. About RecursionRecursion (NASDAQ: RXRX) is...

MAYFIELD VILLAGE, OHIO, Feb. 18, 2026 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended January 31, 2026:  January(millions, except per share amounts and ratios; unaudited) 2026   2025   ChangeNet premiums written $ 6,735   $ 6,481   4   %Net premiums earned $ 6,921   $ 6,586   5   %Net income $ 1,163   $ 1,117   4   %Per share available to common shareholders $ 1.98   $ 1.90   4   %Total pretax net realized gains (losses) on securities $ 103   $ 109   (6 ) %Combined ratio   84.4     84.1   0.3   pts.Average diluted equivalent common shares   587.7     587.7   0   %   January 31,(thousands; unaudited) 2026   2025   % ChangePolicies in Force          Personal Lines          Agency – auto 10,855   9,882   10Direct –...

— Approval decisions from EMA, UK and Switzerland regulators for obicetrapib and obicetrapib/ezetimibe fixed dose combination expected in 2H26 — — Phase 3 PREVAIL CVOT blinded event rate tracking in line with observed event rate in BROADWAY–         — Topline data from RUBENS Phase 3 trial in patients with type 2 diabetes and metabolic syndrome expected by year-end 2026 — — $728.9 million in cash, cash equivalents and marketable securities at December 31, 2025 — NAARDEN, the Netherlands and MIAMI, Feb. 18, 2026 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein...

Strong financial and operational performance in 2025 MISSISSAUGA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2025 and full year 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada’s leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.1% interest in Kruger Products. Kruger Products Q4 2025 Business and Financial HighlightsRevenue was $560.1 million in Q4 2025 compared to $539.6 million in Q4 2024, an increase of $20.5 million or 3.8%. Adjusted...

Full Year Net Sales were $610 million, up 18%, driven by strong Vita Coco Coconut Water growth of 26% Full Year Net Income Increased $15 million to $71 million and Non-GAAP Adjusted EBITDA1 Increased $14 million to $98 million For Fiscal Year 2026, Expect Net Sales between $680 million and $700 million and Adjusted EBITDA2 between $122 million and $128 million NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the fourth quarter and year-ended December 31, 2025. Fourth Quarter and Full Year 2025 Highlights Compared to Prior Year PeriodNet sales were $128 million, up $0.5 million in the fourth quarter, resulting in full year net sales of $610 million, an increase...

Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 18 February 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Wednesday, February 25, 2026. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EST (1:00 p.m. GMT) to discuss its financial results and provide a business and portfolio update. Audio WebcastThe call will be...

Fourth Quarter HighlightsRevenue was $779 million, up 5.9%, and up 5.2% on an organic constant currency (OCC) basis, a non-GAAP measure. Net income was $197 million, down 6.2% due to gains recognized in the prior year. Adjusted EBITDA, a non-GAAP measure, was $437 million, up 9.8%, and up 6.2% on an OCC basis. Diluted GAAP earnings per share was $1.42, down 1.4%. Diluted adjusted EPS, a non-GAAP measure, was $1.82, up 13.0%. Net cash provided by operating activities was $343 million, up 34.4% and free cash flow, a non-GAAP measure, was $276 million, up 38.0%. We paid a cash dividend of 45 cents per share on December 31, 2025. Our Board of Directors approved a cash dividend of 50 cents per share payable on March 31, 2026, an increase of 11%.  Our Board approved an increase to the share repurchase authorization to $2.5 billion in total.Full-Year...

Net revenues increased 4%Comparable-store sales increased 1.6%Unlimited Wash Club® (“UWC”) memberships increased 7%Opened 16 new greenfield locations TUCSON, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) — Mister Car Wash, Inc. (the “Company”) (Nasdaq: MCW), the nation’s leading car wash brand, today announced its financial results for the quarter and year ended December 31, 2025. “We delivered a strong finish to 2025, highlighted by solid membership growth of 7% in the fourth quarter to end the year with nearly 2.3 million members, positioning us exceptionally well as we enter 2026,” said John Lai, Chairperson and CEO of Mister Car Wash. “In addition, we surpassed $1 billion in revenue for the full year for the first time in our history. These results reflect the consistency of our operating model, the strength of our customer value proposition,...

MONACO, Feb. 18, 2026 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the fourth quarter and year ended December 31, 2025. Discontinued operations as a result of Costamare Bulkers Holdings Limited Spin–Off The financial results for the year ended December 31, 2025 reflect the spin-off of Costamare’s dry bulk business (consisting of Costamare’s dry bulk owned fleet and its dry bulk operating platform, Costamare Bulkers Inc. (“CBI”)) into a standalone public company, which was completed on May 6, 2025. Accordingly, the results of the dry bulk business are presented as discontinued operations for all periods shown. For the year ended December 31, 2025, the results of discontinued operations include the dry bulk business up to May 6, 2025, the effective...

PARIS, Feb. 18, 2026 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (“Constellium” or the “Company”) today reported results for the fourth quarter and the full year ended December 31, 2025. Fourth quarter 2025 highlights:Shipments of 365 thousand metric tons, up 11% compared to Q4 2024 Revenue of $2.2 billion, up 28% compared to Q4 2024 Net income of $113 million compared to a net loss of $47 million in Q4 2024 Adjusted EBITDA of $280 million> Includes positive non-cash metal price lag impact of $67 millionSegment Adjusted EBITDA of $83 million at A&T, $136 million at P&ARP and $5 million at AS&I, and corporate costs of $(11) million, together representing a record fourth quarter for the Company Cash from Operations of $218 million and Free Cash Flow of $110 million Repurchased 2.4...